ZEVRA THERAPEUTICS, INC. Quarterly Costs and Expenses in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Zevra Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q3 2024.
Zevra Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $27.2M, a 49.9% increase year-over-year.
Zevra Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $102M, a 71% increase year-over-year.
Zevra Therapeutics, Inc. annual Costs and Expenses for 2023 was $77.1M, a 46.2% increase from 2022.
Zevra Therapeutics, Inc. annual Costs and Expenses for 2022 was $52.7M, a 152% increase from 2021.
Zevra Therapeutics, Inc. annual Costs and Expenses for 2021 was $20.9M, a 10.7% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$102M	$27.2M	+$9.04M	+49.9%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$92.5M	$23.1M	+$9.08M	+64.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$83.4M	$22.2M	+$6.33M	+39.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$77.1M	$29M	+$17.7M	+156%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	$59.4M	$18.1M	+$8.62M	+90.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023	$50.8M	$14M	-$12M	-46.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	$62.8M	$15.9M	+$10.1M	+173%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$52.7M	$11.3M	+$5.91M	+109%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	$46.8M	$9.5M	+$5.31M	+127%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$41.5M	$26.1M	+$19.9M	+324%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$21.6M	$5.82M	+$667K	+12.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$20.9M	$5.42M	-$156K	-2.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-07
Q3 2021	$21.1M	$4.19M	+$1.05M	+33.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$20M	$6.15M	+$1.84M	+42.6%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12
Q1 2021	$18.2M	$5.16M	-$707K	-12.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$18.9M	$5.58M	-$206K	-3.56%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	$19.1M	$3.14M	-$5.09M	-61.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$24.2M	$4.32M	-$3.48M	-44.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	$27.7M	$5.86M	-$5.51M	-48.4%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	$33.2M	$5.79M			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-12
Q3 2019		$8.23M	-$9.73M	-54.2%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-30
Q2 2019		$7.79M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019		$11.4M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-13
Q3 2018		$18M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.